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Abstract: The Gulf War Illness Consortium (GWIC) was designed to identify objective biomarkers
of Gulf War Illness (GWI) in 1991 Gulf War veterans. The symptoms of GWI include fatigue, pain,
cognitive problems, gastrointestinal, respiratory, and skin problems. Neurotoxicant exposures during
deployment, such as pesticides, sarin, and pyridostigmine bromide pills have been identified as
contributors to GWI. We have also found an association between mild traumatic brain injury (mTBI)
and increased rates of GWI. However, the combined impact of these physical and chemical exposures
has not yet been explored in GWI. The objective of this study was to examine both self-reported mTBI
and exposure to chemical/biological weapons (CBW) as a multiple or two hit model for increased
risk of GWI and other chronic health conditions. The study population included 125 Gulf War (GW)
veterans from the Boston GWIC. Exposure to CBW was reported in 47.2% of the study population,
and 35.2% reported sustaining a mTBI during the war. Results confirmed that those with both
exposures (mTBI and CBW) had higher rates of comorbid chronic health conditions while rates of
GWI were equivalent for mTBI and CBW or mTBI alone. The timing of exposure to mTBI was found
to be strikingly different between those with GWI and those without it. Correspondingly, 42.3%
of GWI cases reported experiencing a mTBI during military service while none of the controls did
(p = 0.0002). Rates of mTBI before and after the war did not differ between the cases and controls.
In addition, 54% of cases compared to 14.3% of controls (p = <0.001) reported being exposed to CBW
during military service. The current study examined the relation of the separate and combined effects
of exposure to mTBI and CBW in 1991 GW veterans. The findings from this study suggest that both
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exposure to mTBI and CBW are associated with the development of GWI and multiple chronic health
conditions and that combined exposure appears to lead to higher risk of chronic health effects.
Keywords: Gulf War Illness; Gulf War; mild traumatic brain injury; chemical weapons;
neurotoxicant exposures
1. Introduction
Exposure to chemical mixtures has long been reported as a potential cause for Gulf War
(GW) veterans’ chronic health symptoms [1–5]. It has been found in numerous studies that GW
veterans with exposure to neurotoxicants, including pesticides, pyridostigmine bromide pills, and
chemical/biological weapons (CBW), have higher rates of chronic symptoms than those without such
exposures [6]. In fact, a recent study found a strong inverse correlation with veterans reporting total
number of chemical alarm sounds heard during the war and total cortical gray matter brain volumes [7].
Additionally, GW veterans with an increased reporting of CBW exposures have more frequently met
criteria for the current GW Illness case definitions [8], including chronic multi-symptom illness
(CMI) [9] and Kansas GWI criteria [10], than those without such exposures [11–13]. The symptoms
that have most often been found to correlate with CBW exposures have been fatigue, muscle aches,
irritability, cognitive impairment, and a depressed and anxious mood. These symptoms notably engulf
multiple organ systems that are reflective of central nervous system (CNS) impairment [2,6,14,15].
Mild traumatic brain injury (mTBI) has been reported as another less intuitive potential factor
in the development of chronic health symptoms experienced by GW veterans that can also affect
CNS functioning [16,17]. Correspondingly, GW veterans with any history of mTBI in the large,
longitudinally followed Ft. Devens cohort (FDC) have been found to have significantly higher rates of
GWI (Kansas and CMI criteria) than those without mTBI [16,17]. In addition, the total number of health
symptoms reported by the Ft. Devens cohort was positively correlated with total number of mTBIs.
These symptoms included CNS and non-CNS body systems. Correspondingly, FDC studies also have
shown differences in veterans with mTBI versus no mTBI in reported health symptoms across multiple
functional domains, including cardiac, dermatological, gastrointestinal, musculoskeletal, neurological,
neuropsychological, and pulmonary [17]. In another smaller cohort, Chao et al. [18] reported that
a history of mTBI was not associated with higher rates of GWI when Kansas criteria or severe CMI
criteria were used, but rather only when mild or moderate CMI criteria were used. This study also
found that the highest rates of mTBI were reported before the war and after the war, with the lowest
rates occurring during the war. However, neither the FDC nor the Chao study assessed the combined
impact of mTBI and CBW exposures during the war on the development of chronic GWI and other
medical outcomes. The results of these two sets of studies raise important questions about the impact
of timing of the mTBI on chronic health symptoms and the development of chronic GWI symptoms.
Given that both mTBI and CBW have the capacity to influence CNS function, it is possible that
those who have experienced both “exposures” may have higher rates of chronic symptoms than those
with only one or neither as part of a “two hit” or “multiple hit” scenario. What has been lacking in
the literature on GWI is the relative impact of these multiple exposures (e.g., TBI and CBW) on health
symptoms and the documentation as to whether or not there is an interaction of the two in terms of
chronicity of health outcomes. Therefore, the purpose of this study was to document a “multiple hit
hypothesis” in GWI. Multiple hit hypotheses investigate the effects of multiple risk factors or insults,
additive or interactive, on an outcome. Numerous studies have utilized the multiple hit hypothesis to
investigate nervous system insults on various outcome measures [19–23]. The current study compared
multiple GW exposures (mTBI and CBW) in a more representative sample of GW veterans than those
mentioned above from different parts of the country, representing all branches of the military and with
varying occupational specialties during the war.
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It was hypothesized that GW veterans who had both a history of mTBI and CBW exposures
would have increased rates of GWI and other chronic health outcomes compared to GW veterans
who had only a history of mTBI or only CBW toxicant exposure. GW veterans with multiple “hits”
during the war would be at significantly greater risk for illness than those with no “hits” during the
war. It was also hypothesized that GW veterans who had both a history of mTBI and CBW exposures
(“two hits”) would have increased rates of health outcomes compared to GW veterans who had only a
history of mTBI or only CBW exposure. To our knowledge, this is the first paper to assess the impact of
CBW exposure and mTBI during the war on GWI and other chronic health outcomes in GW veterans
in a new more representative sample of GW veterans recruited as part of the Boston multi-site Gulf
War Illness Consortium (GWIC).
2. Materials and Methods
2.1. Participants
The study population included 125 GW veterans from the Boston University Gulf War Illness
Consortium (GWIC). The GWIC is a multi-site consortium with three clinical sites around the country
(Boston, Miami, and Houston). The inclusion criteria required deployment to the Gulf War between
August 1990 and July 1991. The exclusion criteria for the study included diagnoses that could otherwise
account for the symptoms reported by the veterans. This included autoimmune, central nervous
system, or major psychiatric disorders that may affect brain and immune functions (e.g., epilepsy,
stroke, severe head injury, brain tumor, multiple sclerosis, Parkinson’s disease, Alzheimer’s disease,
schizophrenia, bipolar disorder, and autoimmune disorders). The Kansas GWI case criteria required
endorsement of at least 3 out of 6 symptom domains (fatigue, pain, neurological, skin, gastrointestinal,
and respiratory) of at least moderate severity. GW veterans not meeting Kansas or exclusionary criteria
were considered controls. Once enrolled, subject data were obtained between 2013 and 2018.
2.2. Self-Reported Mild Traumatic Brain Injury (mTBI)
To assess the occurrence of mTBI, participants were provided with a definition of concussion
consistent with current guidelines from the American Academy of Neurology, which has been used
in several recent publications [24–26]. This definition clarifies what constitutes a mTBI and provides
examples of common symptoms [24]. The following description was provided to the participants;
“Some people have the misconception that mild traumatic brain injury (also known as ‘concussion’)
only happens when you lose consciousness after being hit on the head or when the symptoms last
for a long time. However, a mild traumatic brain injury occurs anytime you have an impact to the
head that causes symptoms for any amount of time (e.g., seconds or longer). These symptoms include:
sensitivity to light or noise, headache, dizziness, balance problems, nausea, vomiting, trouble sleeping,
fatigue, confusion, difficulty remembering, difficulty concentrating, or loss of consciousness.”
Participants were asked to report whether they had experienced any mTBIs during three
time-periods: before the war, during the war, and after the war. In addition, they were asked to
self-report how many mTBIs they sustained during each of those periods given this definition and to
be sure to include those from participation in sports.
2.3. Demographics, Chemical/Biological Weapon (CBW) Exposure, and Health Outcome Surveys
GWIC subjects were administered a general demographic information and medical conditions
questionnaire, the Kansas Gulf War and Health Questionnaire and Kansas Gulf War Experiences and
Exposure Questionnaire, and the Structured Neurotoxicant Assessment Checklist (SNAC) [6,10,27].
Self-reported exposures were obtained from the SNAC [6]. For the purpose of this study, we analyzed
the SNAC self-reported exposure to CBWs by asking whether or not they were exposed during
military service. Health outcomes were measured by a medical conditions questionnaire in which the
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participant endorsed whether or not they had a confirmed diagnosis of any of the 20 queried health
outcomes, including asthma, diabetes, respiratory problems, hypertension, memory loss, chronic
fatigue syndrome, and irritable bowel syndrome [6].
2.4. Clinical Interview
The Clinician Administered Posttraumatic Stress Disorder Scale (CAPS) [28] and Structured
Clinical Interview for Diagnostic and Statistical Manual 4 Diagnosis (SCID) [29] were administered to
each participant by a trained examiner. The CAPS for Diagnostic and Statistical Manual 4th edition
(DSM-IV) asked the participant to describe any traumatic event and to answer direct questions about
symptoms relating to intrusions, avoidance, and cognitive and mood alterations secondary to the
event. The SCID was also an interview-based survey enquiring about specific symptoms relating to
psychiatric diagnoses. For the purpose of this study, the utilized modules included those for major
depression, bipolar disorder, and anxiety disorders other than post-traumatic stress disorder (PTSD).
2.5. Data Analysis
We evaluated the association between mTBI and CBW exposure and demographic and health
outcomes in 125 GWIC study participants. Chi-square and one-way ANOVA tests were used,
as appropriate, to compare exposure groups for descriptive purposes. Separate, unadjusted logistic
regressions were performed to determine the effect of mTBI, CBW exposure, and simultaneous mTBI
and CBW exposure during military service on health outcomes. Unadjusted Odds Ratios (OR) and
95% confidence intervals (CI) from regression models are reported. Analyses were conducted using
2-sided tests and an alpha level of 0.05. All analyses were conducted using SAS 9.4 (Statistical Analysis
Systems, Cary, NC, USA).
3. Results
3.1. Participant Characteristics
The first 125 GWIC participants from three parts of the country made up the study sample.
The study sample was 84.8% male with a mean age of 51.5 years. The majority of participants were
white (74.4%) and highly educated, with 82.4% of the population having at least a two-year college
degree (Table 1). The study sample was representative of all branches of the military. Army was the
most common branch of service (67.2%), followed by Navy (16.0%), Marines (10.4%), and then Air
Force (6.4%). In this sample of GW veterans, 34 had a current diagnosis of PTSD as determined by the
CAPS criteria while 83.2% of the cohort met the Kansas GWI case criteria.
Table 1. Population characteristics.
Total Sample = 125
Age, years: Mean (SD) 51.5 (6.0)
Females: n (%) 19 (15.2%)
Race: n (%)
Black/African America n 18 (14.4%)
White/Caucasian 93 (74.4%)
Other/Multiracial 14 (11.2%)
Hispanic or Latino: n (%) 12 (9.6%)
Education: n (%)
Grade 12 8 (6.4%)
GED 1 (0.8%)
HS plus technical training 13 (10.4%)
Associate/2 years college 29 (23.2%)
Some college 17 (13.6%)
Bachelors 22 (17.6%)
Advanced degree 35 (28.0%)
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Table 1. Cont.
Total Sample = 125
Military Branch: n (%)
Army 84 (67.2%)
Marines 13 (10.4%)
Navy 20 (16.0%)
Air Force 8 (6.4%)
Current PTSD: n (%) [n = 91] 34 (37.4%)
GWI Case (Kansas): n (%) 104 (83.2%)
Self-reported mTBI, during deployment: n (%) 44 (35.2%) [Mean SD among those with: 2.0 (1.4)]
Self-reported mTBI, prior to deployment: n (%) 46 (36.8%) [Mean SD among those with: 2.5 (2.3)]
Self-reported mTBI, after deployment: n (%) 33 (26.4%) [Mean SD among those with: 2.4 (2.0)]
Self-reported chemical/biological exposure: n (%) 59 (47.2%)
Note: GED = General Equivalency Degree, HS = high school, PTSD = post-traumatic stress disorder, mTBI = mild
traumatic brain injury, GWI = Gulf War Illness.
3.2. CBW and mTBI Self-Reported Exposures in GWIC Cohort
CBW exposure during military service was reported in 47.2% of the GWIC study population and
35.2% reported sustaining a mTBI during the war. Subjects were also asked to report mTBI during
their lifetime including before, during, and after the war. In the overall study population, 36.8% of
veterans reported having a mTBI before the war, 35.2% reported experiencing a mTBI during the war,
and 26.4% reported having a mTBI after the war (Table 1).
3.3. Results of mTBI and CBW Self-Reported Exposure by GWI Case Status
Statistically significant differences were found between the veterans who self-reported mTBI and
CBW exposure during military service by GWI case status. GW veterans with GWI were much more
likely to have reported experiencing CBW exposure during military service. Fifty-four percent of
cases compared to 14.3% of controls (p = <0.001) reported being exposed to CBW. In addition, the
time-period of exposure was found to be of great importance when examining whether the veterans
with GWI experienced any mTBIs. Correspondingly, 42.3% of GWI cases reported experiencing a mTBI
during the war while none of the controls reported experiencing a mTBI during the war (p = 0.0002)
(Figure 1). Thirty-eight percent of GWI cases reported experiencing a mTBI before the war compared to
33.3% of controls (p = 0.72). Self-reported mTBI after the war was not found to be statistically different
between the two groups (28.9% of cases vs. 14.3% of controls, p = 0.17).Brain Sci. 2018, 8, x FOR PEER REVIEW  6 of 14 
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3.4. Participant Characteristics by Exposure Categories
The study population was classified into four exposure groups based on the following definitions:
mTBI and CBW exposure (yes/yes), mTBI exposure and no CBW exposure (yes/no), no mTBI exposure
and CBW exposure (no/yes), and lastly no mTBI and no CBW exposure (no/no). Examining the
groups in this way allowed us to examine the effect of individual exposure (CBW only and mTBI
only) and the multiple exposure (CBW and mTBI) categories. As a result of small numbers, the mTBI
variable used in the analysis for this paper was limited to self-reported mTBI during the war (yes/no)
and the number of mTBIs was not examined. The number of subjects with GWI significantly differed
by mTBI and CBW groups but was not higher for the combined groups compared with mTBI only
(Table 2). Specifically, 100% of the mTBI/CBW and mTBI-only groups, 90.9% of the CBW-only group,
and 62.5% of the no mTBI/CBW group met the criteria for GWI (p < 0.001). In terms of demographic
comparisons of the four groups, there was a statistically significant difference between the groups in
the number of subjects of Hispanic or Latino descent but no other demographic outcomes differed.
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Table 2. Demographic characteristics by mTBI and chemical/biological weapon (CBW) exposure categories.
Variable n Mean (SD) mTBI & CBW mTBI & No CBW No mTBI & CBW No mTBI & No CBW p-Value
Age n 26 18 33 48 0.50Mean (SD) 50.1 (6.0) 51.3 (5.1) 51.4 (4.9) 52.4 (7.0)
Gender
Female, n (%) 5 (19.2%) 1 (5.6%) 9 (27.3%) 4 (8.3%)
0.07Male, n (%) 21 (80.8%) 17 (94.4%) 24 (72.7%) 44 (91.7%)
Race
Black/African American, n (%) 4 (15.4%) 5 (27.8%) 2 (6.1%) 7 (14.6%)
0.49White/Caucasian, n (%) 18 (69.2%) 11 (61.1%) 28 (84.8%) 36 (75.0%)
Other/Multiracial, n (%) 4 (15.4%) 2 (11.1%) 3 (9.1%) 5 (10.4%)
Hispanic or Latino Yes, n (%) 6 (23.1%) 1 (5.6%) 0 (0.0%) 5 (10.4%) 0.03No, n (%). 20 (76.9%) 17 (94.4%) 33 (100.0%) 43 (89.6%)
Education
Grade 12, n (%) 0 (0.0%) 2 (11.1%) 0 (0.0%) 6 (12.5%)
0.50
GED, n (%) 0 (0.0%) 0 (0.0%) 1 (3.0%) 0 (0.0%)
HS plus technical training, n (%) 3 (11.5%) 4 (22.2%) 2 (6.1%) 4 (8.3%)
Associate/2 years college, n (%) 6 (23.1%) 5 (27.8%) 9 (27.3%) 9 (18.8%)
Some college, n (%) 5 (19.2%) 2 (11.1%) 4 (12.1%) 6 (12.5%)
Bachelors, n (%) 6 (23.1%) 2 (11.1%) 6 (18.2%) 8 (16.7%)
Advanced degree, n (%) 6 (23.1%) 3 (16.7%) 11 (33.3%) 15 (31.3%)
Current PTSD (n = 91) Yes, n (%) 10 (50.0%) 2 (22.2%) 8 (33.3%) 14 (36.8%) 0.49No, n (%) 10 (50.0%) 7 (77.8%) 16 (66.7%) 24 (63.2%)
GWI case (Kansas)
Yes, n (%) 26 (100.0%) 18 (100.0%) 30 (90.9%) 30 (62.5%)
<0.01No, n (%) 0 (0.0%) 0 (0.0%) 3 (9.1%) 18 (37.5%)
Military Branch
Army, n (%) 18 (69.2%) 11 (61.1%) 26 (78.8%) 29 (60.4%)
0.68
Marines, n (%) 3 (11.5%) 2 (11.1%) 4 (12.1%) 4 (8.3%)
Navy, n (%) 3 (11.5%) 4 (22.2%) 2 (6.1%) 11 (22.9%)
Air Force, n (%) 2 (7.7%) 1 (5.6%) 1 (3.0%) 4 (8.3%)
mTBI = mild traumatic brain injury; CBW = chemical/biological weapons, GED = General Equivalency Diploma, HS = high school, PTSD = post-traumatic stress disorder, GWI = Gulf
War Illness.
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3.5. Kansas Criteria by Exposure Group
As described above, all of the veterans with both mTBI and CBW exposure met the criteria for
GWI, as defined by the Kansas criteria (Table 2). Upon further examination, it was evident that those
veterans with both exposures (mTBI and CBW) endorsed symptoms in all six symptom domains
(fatigue, pain, neurological, skin, gastrointestinal, and respiratory) and significantly more symptoms in
each domain (Figure 2). This profile was also seen in the exposure group with CBW only. The exposure
group defined as mTBI-only endorsed a significantly higher percent of symptoms in the fatigue,
neurological, and gastrointestinal symptom domains compared to the unexposed group.
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Figure 2. a sas symptom domains by mTBI and CBW groups. * p < 0.05, ** p < 0.005 for
comparison with reference group (no mTBI & no CBW exposure), mTBI = mild traumatic brain injury,
CBW = chemical/ biological weapons.
3.6. Association between Exposure Groups and r ditions
Elevated unadjusted od s ratios, re i tical significance, were found in four chronic
conditions and across all three xposure groups when compared with the non-e s r ( l 3).
Increased odds of having respiratory allergies or sinus proble s, repeated trouble with neck, back
or spine, memory loss, and depression was seen in the CBW exposure vs. no exposure groups,
the mTBI exposure vs. no exposure, and the dual mTBI and CBW exposure vs. no exposure group.
Two additional chronic conditions had statistically significant elevated odds ratios in both the CBW
exposure vs. no exposure and the dual mTBI and CBW exposure vs. no exposure groups. These two
chronic conditions were chronic fatigue syndrome and irritable bowel syndrome. The remaining eight
health outcomes with statistically significant elevated odds ratios were only seen in the dual mTBI
and CBW exposure groups and included asthma, high sugar or diabetes, blindness or trouble seeing
with either eye, chronic lung disease, chronic skin conditions, deafness or trouble hearing in either
ear, chemical sensitivity, and “other” gastrointestinal disorders. In summary, a total of 12 chronic
conditions had statistically significant elevated odds ratios in the dual mTBI and CBW exposure group,
six chronic conditions for the group exposure to CBW exposures only, and four chronic conditions for
those with mTBI exposures only during the war.
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Table 3. Unadjusted logistic regression analysis examining CBW exposure, mTBI exposure, and mTBI + CBW.
Variable
CBW Exposure Only vs. Neither mTBI Exposure Only vs. Neither mTBI + CBW Exposure vs. Neither
OR (95% CI) OR (95% CI) OR (95% CI)
High Blood Pressure 0.80 (0.32,1.99) 2.80 (0.90,8.72) 0.88 (0.33,2.32)
Heart Attack or MI 1.47 (0.09,24.35) 2.76 (0.16,46.70) 1.88 (0.11,31.35)
Asthma 1 5.11 (0.96,27.13) 2.87 (0.37,22.13) 6.90 (1.28,37.18) *
High sugar/diabetes 1 2.07 (0.43,9.92) 4.28 (0.85,21.49) 4.50 (1.02,19.81) *
Respiratory allergies or sinus problems 1,2,3 5.88 (2.16,16.00) * 5.42 (1.67,17.61) * 6.93 (2.37,20.26) *
Arthritis, rheumatism or gout 1.54 (0.59,3.99) 2.69 (0.88,8.27) 1.68 (0.61,4.64)
Repeated trouble with neck, back or spine 1,2,3 3.30 (1.30,8.35) * 4.86 (1.52,15.51) * 10.20 (3.21,32.44) *
Blindness or trouble seeing with either eye 1 3.33 (0.77,14.44) 4.29 (0.85,21.50) 7.94 (1.92,32.88) *
Chronic lung disease 1 4.70 (0.47,47.30) 9.40 (0.91,97.25) 20.89 (2.44,179.09) *
Chronic skin conditions 1 2.93 (0.99,8.62) 2.25 (0.61,8.32) 6.83 (2.25,20.78) *
Memory loss 1,2,3 5.67 (2.05,15.65) * 3.97 (1.22,12.95) * 8.39 (2.50,28.21) *
Deafness or trouble hearing in either ear 1 1.62 (0.57,4.67) 2.76 (0.84,9.09) 4.33 (1.51,12.46) *
Depression 1,2,3 2.64 (1.05,6.61) * 4.40 (1.39,13.96) * 4.16 (1.51,11.44) *
Current PTSD [N = 91] 0.86 (0.29, 2.51) 0.49 (0.09, 2.69) 1.71 (0.57, 5.13)
Chemical sensitivity 1 2.62 (0.83,8.27) 3.50 (0.95,12.85) 8.17 (2.58,25.83) *
Chronic Fatigue Syndrome 1,2 5.17 (1.96,13.65) * 2.69 (0.85,8.48) 9.13 (3.05,27.35) *
Irritable Bowel Syndrome 1,2 4.71 (1.82,12.22) * 1.71 (0.55,5.37) 4.31 (1.56,11.88) *
Other GI disorders 1 1.46 (0.55,3.87) 1.12 (0.33,3.81) 3.40 (1.24,9.36) *
* = statistically significant. 1 = statistically significant difference between multiple exposure (mTBI + CBW) and no exposure. 2 = statistically significant difference between
chemical/biological-weapons-only exposure and no exposure. 3 = statistically significant difference between mTBI-only exposure and no exposure. mTBI = mild traumatic brain injury;
CBW = chemical/biological weapons; MI = myocardial infarction; GI = gastrointestinal.
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4. Discussion
The current study examined a multiple hit hypothesis (mTBI and CBW) in 1990–1991 GW veterans
in relation to GWI and chronic medical conditions. To our knowledge, this is the first paper to examine
exposure to both mTBI and a neurotoxicant (CBW) in relation to GWI. In our previous studies, we
investigated the multiple hit hypothesis using two neurotoxicants known to be frequent in the GW,
pesticides, and pyridostigmine bromide (PB) pills. We found a strong synergistic effect of these mixed
exposures on GWI and cognitive outcomes [1]. Given the brevity of the GW ground war, mTBI has not
been investigated as a primary factor of GWI until recently. In our recent work with the Ft. Devens
Cohort, veterans with mTBI had increased rates of GWI as determined by Centers for Disease Control
(CDC) and Kansas GWI criteria [16,17]. These studies also showed that the increased number of mTBIs
was associated with higher number of total symptoms reported [16]. However, the timing of the
mTBI was not available for the Ft. Devens Cohort studies, leaving open the question of whether the
proximity of the mTBI to CBW exposure had an impact on the rates of GWI and comorbid chronic
health conditions.
Findings from the current study identified a surprisingly strong effect of timing of mTBI during
the war and GWI in that those who experienced a mTBI during the war were statistically significantly
more likely to endorse symptoms consistent with GWI than those who did not report mTBI during
the war. Conversely, rates of mTBI in the GWI cases and controls did not differ before or after the
war, indicating that the timing of the mTBI insult appeared to be critical to development of chronic
health symptoms. These results add an important concept to consider when doing GWI research. This
suggests that brain sequelae of mTBI as well as neurotoxicant induced brain changes, including white
matter (WM) macro and microstructural integrity alterations [30–32], should be considered as prime
candidates in the chronic CNS pathobiology of GWI.
The only other study reporting on mTBI rates in GW veterans found remarkably similar rates to
ours with 47% of their GW veteran cohort and 46% of our GWIC cohort reporting a history of ever
having an mTBI [18]. Chao also reported that only 7% of her sample as compared with 36% of our
sample reported mTBIs sustained during the war. Chao did not find an association between the history
of mTBI during the war and GWI, however the study did find that those with mTBI during the war
had increased chronic symptoms. The lack of association with GWI could be influenced by the small
sample size of veterans who sustained a mTBI during the war (n = 7). However, our data showed an
association between mTBI such that nearly half of our cases and none of our controls reported a mTBI
during the war. The differences in respective rates of mTBIs during the war may reflect the military
occupational specialties (MOS) of our cohort. Our multi-site GWI consortium was more representative
of the whole GW veteran cohort because participants were recruited from three sites across the country
(Boston, Houston, and Miami), had varied MOS, and represented every branch of military service,
making them representative of all deployed GW veterans.
The most relevant findings of this study included the replication of results from our previous work
that mTBI is associated with increased rates of GWI. In relation to comorbid health conditions, findings
emerged that confirm our hypothesis of a synergistic effect, with increased odds ratios for those with
both mTBI and CBW on 12 of the total medical conditions. In essence, the “two hit” group showed
more than double the reporting of chronic conditions than the “one hit” groups. Correspondingly,
in this study, we report that GW veterans with both mTBI and CBW had significantly increased
health symptoms across all six Kansas GWI criteria domains, including fatigue, pain, neurologic, skin,
gastrointestinal, and respiratory symptoms [10]. These results suggest that more than the CNS is
affected in these groups.
However, confirmation of our original hypothesis that multiple exposures in this two hit model
(mTBI and CBW) are consistent with increased rates of GWI was not found in that the rate of GWI
did not differ between those with multiple versus single hits. The difference in the rates of GWI may
have been obscured because individuals with mTBI and no CBW may have had other exposures,
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including sarin, pesticides, and PB pills that were not accounted for in these analyses. These additional
neurotoxicant exposures could have influenced the rates of GWI in those without CBW.
While the current study cannot confirm the etiology for GWI symptoms, several studies
suggest that the neurotoxicant exposures experienced in war can lead to an increased immune
response, not only in the brain, but throughout the body [33–36]. Likewise, TBIs can also lead
to an increased neuroinflammatory state by priming the immune cells of the brain—microglia and
astrocytes—to respond longer and stronger after each additional encounter with foreign or “danger”
associated molecular patterns (DAMPS) from damaged or apoptotic neural cells [37–41]. This chronic
inflammatory overactivation has now been termed post-inflammatory brain syndrome (PIBS) [42].
GWI sequelae fits this profile and can be considered a result of PIBS depending on the individual
veterans’ “danger” exposure history (i.e., multiple toxicant or mTBI exposures or both).
Consistent with the literature on multiple hits, when more than one exposure occurs, more CNS
dysfunction and other body systems are affected [16,43]. In this scenario, damaged or apoptotic cells
from the brain can signal into the periphery and vice-versa from a leaky blood brain barrier (BBB) or
gut-brain axis [36,44,45]. Future studies should further investigate the pathobiology of this multiple
hit hypothesis.
Like all studies, this study had several limitations worth mentioning. First, the use of a relatively
small cohort of GW veterans who self-reported exposures during the war suggests that further study
is warranted in larger study samples. Second, the mTBI and CBW exposures were self-reported and
the chronic conditions were not confirmed by medical records. However, the veterans did endorse that
their chronic conditions had been diagnosed by a physician. Although the sample size of the groups
was modest, it was more representative than other cohorts reporting on neurotoxicant and mTBI
outcomes published to date in that it represented GW veterans from all branches of the military and
three study sites around the country. Third, we examined associations on 18 outcome measures across
four exposure groups, and, given our limited sample size, we did not control for multiple comparisons.
However, we found elevated risks for 12 out of 18 outcomes in the multiple hit exposure group, which
was far more than would be expected by chance. There remain questions about the timing of the
mTBI and CBW exposures that could not be answered in this study, such as whether mTBI exposure
increases CBW toxicity. It was also unclear whether mTBI is specific to the multiple hits needed for
chronic conditions or if it represented a proxy for other exposure combinations during deployment.
5. Conclusions
The current study examined the relation of the separate and combined effects of exposure to mTBI
and CBW in 1991 GW veterans. The findings from this study suggest that both exposure to mTBI and
CBW are associated with the development of GWI and multiple chronic health conditions and that
combined exposure appears to lead to higher risk of chronic health effects.
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